Antares Pharma buy melinda
Start price
08.10.17
/
50%
€3.58
Target price
19.12.17
€3.79
Performance (%)
-48.24%
End price
19.12.17
€1.85
Summary
This prediction ended on 19.12.17 with a price of €1.85. The BUY prediction by melinda for Antares Pharma performed very badly with a performance of -48.24%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Antares Pharma | - | - | - | - |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% | 70.602% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% | 103.322% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% | 44.593% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% | 64.741% |
Comments by melinda for this prediction
In the thread Antares Pharma diskutieren
pharma
Kaution ANDS angekündigt 17. April 2017. PDUFA Datum 17. Oktober 2017 eine vorrangige Prüfung von 6 Monaten angenommen.
(Vom Mitglied beendet)


